Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 6, 2004, Pages 1773-1776

  Koontz, Stephanie L ^a   Friedman, Steven A ^a   Schwartz, Martin L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hypocalcemia; Magnesium sulfate; Nifedipine

Indexed keywords

BETAMETHASONE; GLUCONATE CALCIUM; MAGNESIUM SULFATE; NIFEDIPINE;

ADULT; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; CONTRACTURE; DELIVERY; FEMALE; HUMAN; HYPOCALCEMIA; LUNG EDEMA; MEDLINE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL;

ADULT; CALCIUM GLUCONATE; FEMALE; GESTATIONAL AGE; HUMANS; HYPOCALCEMIA; MAGNESIUM SULFATE; MATERNAL AGE; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PARITY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOCOLYSIS; TREATMENT OUTCOME;

EID: 3442887100     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.02.050     Document Type: Conference Paper

References (18)

1. Monif G.R.G., Savory J. Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA. 219:1972;1469-1470
2. Davis W.B., Wells S.R., Kuller J.A., Thorp J.M. Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist. Obstet Gynecol Surv. 52:1997;198-201
3. Cruikshank D.P., Pikin R.M., Donnelly E., Reynolds W.A. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion. Obstet Gynecol. 58:1981;430-434
4. Cholst I.N., Steinberg S.F., Tropper P.J., Fox H.E., Segre G.V., Bilezikian J.P. The influence of hyermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med. 310:1984;1221-1225
5. Cruikshank D.P., Pitkin R.M., Reynolds W.A., Williams G.A., Hargis G.K. Effects of magnesium sulfate treatment on perinatal calcium metabolism I. Maternal and fetal responses. Am J Obstet Gynecol. 134:1979;243-249
6. Smith L.G., Burns P.A., Schanler R.J. Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm labor. Am J Obstet Gynecol. 167:1992;45-51
7. Monif. Ibid.
8. Eisenbud E., Lobue C.C. Hypocalcemia after therapeutic use of magnesium sulfate. Arch Intern Med. 136:1976;688-691
9. Mayan H., Hourvitz A., Schiff E., Farfel Z. Symptomatic hypocalcemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy-possible involvement of the calcium-sensing receptor. Nephrol Dial Transplant. 14:1999;1764-1766
10. Levav A.L., Chan L., Wapner R.J. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report. Am J Perinatol. 15:1998;43-46
11. Bosso J.V., Gazzara P.C., Rosati M. Tetany associated with Nifedipine. N Engl J Med. 315:1986;584-585
12. Snyder S.W., Cardwell M.S. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol. 161:1989;35-36
13. Ben-Ami M., Giladi Y., Shalev E. The combination of magnesium sulfate and Nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol. 101:1994;262-263
14. Pecha R.E., Danilewitz M.D. Acute pseudo-obstruction of the colon (Ogilvie's Syndrome) resulting from combination tocolytic therapy. Am J Gastroenterol. 91:1996;1265-1266
15. Fenakel K., Fenakel G., Appelman Z., Lurie S., Katz Z., Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol. 77:1991;331-337
16. Scardo J.A., Vermillion S.T., Hogg B.B., Newman R.B. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 175:1996;336-340
17. Waisman G.D., Mayorga L.M., Camera M.I., Vignolo C.A., Martinotti A. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol. 159:1988;308-309
18. Friedman S.A., Schiff E., Lubarsky S.L., Sibai B.M. Expectant management of severe preeclampsia remote from term. Clinic Obstet Gynecol. 42:1999;470-478